Search results for "Thyroid Hormone"

showing 10 items of 166 documents

Intact parathyroid hormone value on the first postoperative day following total thyroidectomy as a predictor of permanent hypoparathyroidism: a retro…

2022

Introduction: Hypoparathyroidism represents a common complication following total thyroidectomy. To date, there is still no reliable and immediate postoperative parameter to establish which patients with postsurgical hypoparathyroidism will develop permanent hypoparathyroidism. The main purpose of the present study was to assess whether the intact parathyroid hormone (iPTH) value on the first postoperative day is a good predictor of permanent hypoparathyroidism. Material and methods: Patients undergoing thyroidectomy in our unit between March 2018 and January 2020 were analysed. According to the iPTH value on the first postoperative day and on the basis of the detection threshold of the iPT…

ComplicationsPostoperative ComplicationsEndocrinologyIntact parathyroid hormoneHypocalcemiaPermanent hypoparathyroidismHypoparathyroidismParathyroid HormoneEndocrinology Diabetes and MetabolismThyroidectomyHumansCalciumRetrospective StudiesEndokrynologia Polska
researchProduct

Biomineralisations in crustaceans: storage strategies

2004

Abstract Crustaceans are a remarkable group of animals because of their ability to elaborate cyclically two kinds of calcified biomineralisations: an unstretchable exoskeleton (or cuticle) and also, for many species, depending of the way of life of the considered animal, transitory calcium deposits. They are in consequence subjected to a cyclic life and notably, to a periodical balance between two sources of calcium, exogenous and/or endogenous. The storage structures, essentially composed of calcium carbonate precipitated within a proteinaceous organic matrix, are very diversified. The calcium carbonate of the cuticle of most of the species is under a crystalline state and/or an amorphous …

CuticleGeneral EngineeringParathyroid hormonechemistry.chemical_elementBiologyCalciummedicine.diseaseCalcium in biologychemistry.chemical_compoundCalcium carbonatechemistryBiochemistrymedicineCarbonateCalcificationBiomineralizationComptes Rendus Palevol
researchProduct

Mid-region parathyroid hormone-related protein (PTHrP) and gene expression of MDA-MB231 breast cancer cells.

2007

Abstract We have previously shown that PTHrP(38–94) amide restrains growth and invasion in vitro, causes striking toxicity and accelerates death of some breast cancer cell lines, the most responsive being MDA-MB231, for which tumorigenesis was also attenuated in vivo. We have also demonstrated that mid-region PTHrP gains access to the nuclear compartment of these cells and displays DNA-binding properties in vitro by recognizing targets in both cellular chromatin and isolated oligonucleotides. Here, we examined whether PTHrP(38–94) amide was able to modulate gene expression of MDA-MB231 cells, employing a combination of conventional, differential display and semi-quantitative multiplex PCR t…

Differential displayParathyroid hormone-related proteinChemistryClinical BiochemistryMolecular Sequence DataParathyroid Hormone-Related ProteinBreast Neoplasmsmedicine.disease_causeBiochemistryIn vitroChromatinGene Expression Regulation NeoplasticCell Line TumorGene expressionmedicineCancer researchCytotoxic T cellHumansCarcinogenesisMolecular BiologyReprogrammingBiomarkersChromosomes Human Pair 8Biological chemistry
researchProduct

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma.

2007

T cell functional differentiation is mediated by lineage-specific transcription factors. T helper 17 (Th17) has been recently identified as a distinct Th lineage mediating tissue inflammation. Retinoic acid receptor-related orphan receptor gamma (ROR gamma) was shown to regulate Th17 differentiation; ROR gamma deficiency, however, did not completely abolish Th17 cytokine expression. Here, we report Th17 cells highly expressed another related nuclear receptor, ROR alpha, induced by transforming growth factor-beta and interleukin-6 (IL-6), which is dependent on signal transducer and activator of transcription 3. Overexpression of ROR alpha promoted Th17 differentiation, possibly through the c…

Encephalomyelitis Autoimmune ExperimentalReceptors Retinoic AcidT cellImmunologyRetinoic acidReceptors Cytoplasmic and NuclearElectrophoretic Mobility Shift AssayBiology03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineT-Lymphocyte SubsetsmedicineT helper 17 cellImmunology and AllergyAnimalsCell LineageReceptorMOLIMMUNOTranscription factor030304 developmental biologyOrphan receptor0303 health sciencesReceptors Thyroid HormoneReverse Transcriptase Polymerase Chain ReactionInterleukin-17Cell DifferentiationNuclear Receptor Subfamily 1 Group F Member 1T-Lymphocytes Helper-InducerNuclear Receptor Subfamily 1 Group F Member 3Molecular biologyMice Mutant StrainsCell biologymedicine.anatomical_structureInfectious DiseaseschemistryNuclear receptorSTAT proteinTrans-ActivatorsFemale030215 immunologyImmunity
researchProduct

Midregion PTHrP and Human Breast Cancer Cells

2010

PTHrP is a polyhormone undergoing proteolytic processing into smaller bioactive forms, comprising an N-terminal peptide, which is the mediator of the “classical” PTH-like effect, as well as midregion and C-terminal peptides. The midregion PTHrP domain (38-94)-amide was found to restrain growth and invasionin vitroof some breast cancer cell lines, causing striking toxicity and accelerating death; the most responsive being MDA-MB231, whose tumorigenesis was also attenuatedin vivo. In addition, midregion PTHrP appears to be imported in the nucleoplasm of cultured MDA-MB231 cells andin vitro, it can bind chromatin of metaphase spread preparations and also an isolated 20-mer oligonucleotide, the…

Gene Expressionlcsh:MedicineBreast NeoplasmsDNA FragmentationBiologymedicine.disease_causelcsh:TechnologyGeneral Biochemistry Genetics and Molecular BiologyTranscription (biology)Cell Line TumorPTHrP breast cancer cancer cell gene expression cytotoxicityGene expressionmedicineHumansSettore BIO/06 - Anatomia Comparata E CitologiaMDA-MB231lcsh:ScienceDNA statusGeneral Environmental ScienceMini-Review ArticleNucleoplasmlcsh:Tmidregion PTHrPlcsh:RParathyroid Hormone-Related ProteinapoptosisGeneral MedicineMolecular biologynuclear importIn vitroCell biologyChromatinPTHrP (38-94)Cancer cellprotein degradationFemalelcsh:QCarcinogenesisReprogrammingbreast cancer cellsThe Scientific World Journal
researchProduct

PTHrP in differentiating human mesenchymal stem cells: Transcript isoform expression, promoter methylation, and protein accumulation

2013

Human PTHrP gene displays a complex organization with nine exons producing diverse mRNA variants due to alternative splicing at 5' and 3' ends and the existence of three different transcriptional promoters (P1, P2 and P3), two of which (P2 and P3) contain CpG islands. It is known that the expression of PTHrP isoforms may be differentially regulated in a developmental stage- and tissue-specific manner. To search for novel molecular markers of stemness/differentiation, here we have examined isoform expression in fat-derived mesenchymal stem cells both maintained in stem conditions and induced toward adipo- and osteogenesis. In addition, the expression of the splicing isoforms derived from P2 …

Gene isoformTranscription GeneticPTHrPCellular differentiationpromoter methylationBiologyOsteocytesBiochemistryGene expressionAdipocytesHumansProtein IsoformsadipogenesiSettore BIO/06 - Anatomia Comparata E CitologiaPromoter Regions Geneticmesenchymal stem cellCells CulturedMessenger RNAMesenchymal stem cellAlternative splicingParathyroid Hormone-Related ProteinCell DifferentiationMesenchymal Stem CellsExonsGeneral MedicineMethylationDNA MethylationosteogenesiMolecular biologyIntronsPTHrP; mesenchymal stem cells; osteogenesis; adipogenesis; gene expression; promoter methylationAlternative SplicingSettore BIO/18 - GeneticaGene Expression Regulationgene expressionCpG IslandsStem cellBiochimie
researchProduct

Vitamin A modulates the effects of thyroid hormone on UDP-glucuronosyltransferase expression and activity in rat liver.

2002

We studied the influence of thyroid hormones and vitamin A status on the regulation of UDP-glucuronosyltransferase (UGT) expression and the glucuronidation of thyroid hormones by UGTs. For this, we used an original model of rats fed with different vitamin A diets and implanted subcutaneously by osmotic minipumps delivering vehicle or thyroid hormones, which permitted the control of plasma thyroid hormone concentrations. The activity and expression of family 1 UGTs are correlated and were significantly modified by both thyroid status and amounts of retinol in the diet. Dietary vitamin A did not perturbe the UGT1A expression in thyroidectomized animals. Thyroid hormones and dietary vitamin A …

Gene isoformVitaminMaleendocrine systemmedicine.medical_specialtyThyroid Hormonesendocrine system diseasesMonosaccharide Transport ProteinsBilirubinGlucuronidationNaphtholsBiologydigestive systemBiochemistryGene Expression Regulation Enzymologicchemistry.chemical_compoundEndocrinologyInternal medicinemedicineAnimalsGlucuronosyltransferaseRats WistarVitamin AMolecular BiologyThyroidRetinolBilirubinDietRatsThyroxinemedicine.anatomical_structureEndocrinologychemistryLiverThyroid hormonesThyroidectomyTriiodothyronineHormoneMolecular and cellular endocrinology
researchProduct

Expression of synapsin I gene in primary cultures of differentiating rat cortical neurons

1995

Synapsin I is a neuron-specific protein which is present in two isoforms, Ia and Ib. In the last few years this protein has been demonstrated to play a central role in the regulation of neurotransmitter release and synaptic plasticity. In this paper the developmental expression of this protein has been investigated in primary neuronal cultures from fetal rat brain cortices. The presence of thyroid hormone in the culture medium stimulates an early expression of the protein without exerting any effect at the level of mRNA transcription and accumulation. These observations implicate a T3-dependent regulation of this neuron-specific gene at the level of mRNA translation. © 1995 Plenum Publishin…

Gene isoformmedicine.medical_specialtySynapsin ITime FactorsTranscription GeneticBlotting Westernsynapsin IGene ExpressionBiologyBiochemistryCellular and Molecular Neurosciencechemistry.chemical_compoundFetusInternal medicineSettore BIO/10 - BiochimicaGene expressionmedicineAnimalsRNA MessengerNeurotransmitterCells CulturedCell NucleusCerebral CortexNeuronsMessenger RNANeuroscience (all)Cell DifferentiationGeneral MedicineSynapsinBlotting NorthernSynapsinsthyroid hormoneRatsCell biologyKineticsmedicine.anatomical_structureEndocrinologynervous systemchemistryNeuronal differentiationSynaptic plasticityTriiodothyronineSettore MED/26 - NeurologiaNeuron
researchProduct

New point mutation (R243W) in the hormone binding domain of the c‐erbA β1 gene in a family with generalized resistance to thyroid hormone

1996

Two years after the first mutation on exon 7 in the carboxy-terminal part of the hinge domain (D) was reported (Behr and Loos 1992), we have identified the second mutation on exon 7 in patients with GRTH. Interestingly, our mutation it is not located in the two previously described "hot spot regions", but instead very close to the hinge domain (D) of the receptor protein that is essential for the function of the hormone binding domain (E) (Lin et al., 1991). Confirming the observation that the majority of single base substitutions causing human genetic diseases or DNA polymorphisms follow the hot spot mutation rule of CG to TG and CG to CA transition (Barker et al., 1984), an additional CpG…

Geneticsmedicine.medical_specialtyThyroid hormone receptorPoint mutationBiologyThyroid hormone receptor betaExonEndocrinologyCpG siteInternal medicinemedicineGeneticsReceptorGeneGenetics (clinical)Binding domainHuman Mutation
researchProduct

Suplementación de yodo en la gestación y lactancia

2014

l beneficio de la suplementación con yodo durante la gestación en las áreas con deficiencia grave de yodo está bien establecido. En el año 2004 la Organización Mundial de la Salud incluyó a España entre los países con adecuada ingesta de yodo y varios estudios recientes confirman que la ingesta de yodo es suficiente en la población española. Los profesionales españoles, sin embargo, se han encontrado con recomendaciones contradictorias, lo que ha generado confusión e incertidumbre en la práctica a seguir en cuanto a la suplementación de yodo a la mujer gestante o en periodo de lactancia. A los clínicos e investigadores les preocupa que las situaciones de déficit de yodo leve o moderado pued…

GestaciónLactanciaThyroid hormonesPregnancyPediatrics Perinatology and Child HealthHormonas tiroideasYodoBreast feedingIodine
researchProduct